Research [41] has shown that reduced levels of HDL cholesterol or apolipoprotein A1 correlate with elevated risks of multiple myeloma, MPN, non-Hodgkin lymphoma, and breast, lung, and nervous system cancers. This evidence concerns the gene APOA1 and nervous system cancer.